Stock analysts at StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a report issued on Wednesday. The brokerage set a “hold” rating on the stock.
Milestone Scientific Stock Performance
Shares of MLSS opened at $0.98 on Wednesday. The company has a 50-day simple moving average of $0.83 and a 200-day simple moving average of $0.72. Milestone Scientific has a 52 week low of $0.52 and a 52 week high of $1.25. The firm has a market capitalization of $75.69 million, a P/E ratio of -9.80 and a beta of 0.88.
Milestone Scientific (NYSE:MLSS – Get Free Report) last issued its quarterly earnings results on Wednesday, May 15th. The company reported ($0.02) earnings per share (EPS) for the quarter. Milestone Scientific had a negative net margin of 74.50% and a negative return on equity of 93.64%. The firm had revenue of $2.25 million for the quarter.
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Read More
- Five stocks we like better than Milestone Scientific
- What does consumer price index measure?
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- What is Insider Trading? What You Can Learn from Insider Trading
- Jeff Brown’s Exegesis AI Stock Picks
- 3 Stocks to Consider Buying in October
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
